ESC3:37New 2026 #ESCGuidelines for the Management of Cardiovascular Disease and Chronic Kidney Disease
- Source
- European Society of Cardiology · YouTube
- Date
- Audio
- English
- Subtitles
- MultilingualYouTube
- Audio transl.
- Unconfirmed · check ⚙YouTube
Medical notice: Educational content only. CanduCardio is intended for healthcare professionals and CanduTV for the general public. It does not replace clinical judgment or professional consultation.
If you don't see subtitles in your language, turn on auto-translate from the player's settings gear (⚙).
Subtitles requested in: English
First try the player's auto-translate: settings gear (⚙) → Subtitles/CC → Auto-translate. If the video has no subtitles at all, your phone or browser can write out what is said in real time. It runs on your own device: CanduCardio receives and stores nothing.
EMPA-KIDNEY2023
Post-trial follow-up showed the benefit of empagliflozin on kidney disease progression or cardiovascular death in chronic kidney disease persisted after the trial drug was stopped.
Educational video published by European Society of Cardiology in 2022. Played with YouTube's official player.
ESC3:37
ESC1:11
ESC1:48
ESC3:07
ESC2:15
RadcliffeCommercial48:57
SVS7:00
HRS14:03